Cargando…
AMPK activation by ASP4132 inhibits non-small cell lung cancer cell growth
Activation of adenosine monophosphate-activated protein kinase (AMPK) is able to produce significant anti-non-small cell lung cancer (NSCLC) cell activity. ASP4132 is an orally active and highly effective AMPK activator. The current study tested its activity against NSCLC cells. In primary NSCLC cel...
Autores principales: | Xia, Ying-chen, Zha, Jian-hua, Sang, Yong-Hua, Yin, Hui, Xu, Guo-qiu, Zhen, Jie, Zhang, Yan, Yu, Ben-tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024326/ https://www.ncbi.nlm.nih.gov/pubmed/33824293 http://dx.doi.org/10.1038/s41419-021-03655-2 |
Ejemplares similares
-
Report no. 11: Test on the "or gate' - CERN-NP type N4132
por: Bianchetti, G, et al.
Publicado: (1967) -
Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration
por: Pereira, Patricia Marques, et al.
Publicado: (2022) -
PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell Growth
por: Zhu, Yun-Rong, et al.
Publicado: (2021) -
The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620
por: Zha, Jian-hua, et al.
Publicado: (2021) -
AdipoR2 inhibits human glioblastoma cell growth through the AMPK/mTOR pathway
por: Jie, Chen, et al.
Publicado: (2021)